NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Diabetes and Metabolism > Short or long sleep associated with pulmonary fibrosis

Short or long sleep associated with pulmonary fibrosis

20 January 2020 · Listed under Diabetes and Metabolism

Scientists have discovered that people who regularly sleep for very long (11 hours or more) or very short (four hours or less) periods of time are two to three times more likely to have the incurable disease pulmonary fibrosis, compared to those that sleep for seven hours in a day.

Photo by Vladislav Muslakov on Unsplash

The researchers attribute this association to the body clock. Their study showed that targeting the body clock reduced fibrosis in vitro, revealing a potential target for a disease that kills about 5,000 people a year in the UK.

The research team included members from the Universities of Manchester, Oxford, Newcastle, University College London and Toronto. Among them was Prof David Ray, a principle investigator in the NIHR Oxford BRC’s Diabetes and Metabolism theme.

The study was published in Proceedings of the National Academy of Sciences and was funded by the Medical Research Council and the Wellcome Trust.

Our internal body clocks regulate nearly every cell in our bodies, driving 24-hour cycles in many processes such as sleeping, hormone secretion and metabolism.

In the lungs, the clock is mainly located in the main airways. However, the team discovered that in people with lung fibrosis, these clock oscillations extend out to the small air spaces, called alveoli. 

Previous studies in mice have found that by altering the clock mechanism it was possible to disrupt the fibrotic process making the animals more likely to develop pulmonary fibrosis.

Using human data from the UK Biobank, the researchers showed that pulmonary fibrosis is associated with short and long sleep duration. The link between sleep duration and lung fibrosis is similar in strength to other known risk factors for this disease.

People who report they regularly sleep four hours or less in a day doubled their chance of having pulmonary fibrosis, while those sleeping 11 hours or longer a day tripled their chance of having the disease, compared to those sleeping seven hours per day.

Smaller, but still elevated, risks were also seen in people who like to stay up late at night or those who do shift work.

The researchers explained their findings by the discovery of a core clock protein (REVERBα), which alters the production of a key protein in lung fibrosis (collagen). They say this is an exciting finding because chemical compounds can alter the function of REVERBα.

The authors were able to show that one of these REVERBα compounds can reduce collagen in lung slices from people with this disease.

They said that the discovery that the body clock is potentially a key player potentially opens new ways to treat or prevent pulmonary fibrosis, although more needs to be done to study the association between the disease and sleep duration to establish both causation and reproducibility.

If the results are confirmed, then sleeping for the optimal time may reduce the impact of this devastating disease.

Previous studies have shown that the clock also plays an important role in infection, cancer and diabetes. The discovery that the clock plays a role in fibrosis suggests that altering these oscillations could become an important therapeutic approach.

← Achieving Type 2 diabetes treatment targets would improve health and reduce healthcare costs
BRC gets European funding for citizen science metabolism project →

News

  • Lymph nodes reveal more about mechanisms of autoimmunity 14 June 2022
  • Conference aims to forge collaborations to tackle dementia 9 June 2022
  • Lung function device wins top chemistry Prize 8 June 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre